Cavitation Technologies, Inc. (CTI) (OTCQB: CVAT) (BERLIN: WTC), received a purchase order from Desmet Ballestra Group, CTi’s strategic partner and licensee of the company’s vegetable oil refining technology since 2010. CTi’s Nano Reactor™ system is to be installed for use in soybean oil refinery in Dominican Republic ~800 metric tonnes per day (MTPD). This is the first purchase order the company has received in Dominican Republic and anticipates the system shipment to be completed in the company’s 1st Fiscal Quarter 2018 and receive approximately $165,000 in revenue.
Cavitation Technologies, Inc. Global Technology Manager, Roman Gordon said, “We dedicate our continuous efforts to accelerate global system sales in vegetable oil refining and biodiesel production, while developing new technologies, patents, innovative industrial equipment and exciting consumer products. This is the second purchase order our company received in Fiscal 2018. This latest order comes from the soybean oil refinery in Dominican Republic, our company’s first system installation in the country.”
About CTi
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement, water treatment, and the extraction of cannabidiol (CBD). As an add-on to its existing neutralization systems, the company’s patented Nano Reactor™ allows refiners to significantly reduce both processing costs and environmental impact, while also increasing yield. http://www.ctinanotech.com/
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
Read Next
